Evidence map›Paper›PMID 31648864›Full record

ArticleOral oncology2020

Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.

V C Sandulache, Y L Lei, L E Heasley, M Chang, C I Amos, E M Sturgis, E Graboyes, E Y Chiao, N Rogus-Pulia, J Lewis and 12 more

Open access · greenAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Oral oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 1 country.

V C SandulacheBobby R. Alford Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States; ENT Section, Operative Care Line, Michael E. DeBakey VA Medical Center, Houston, TX, United States. Electronic address: vlad.sandulache@bcm.edu.
Y L LeiDepartment of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, United States.
L E HeasleyDepartment of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States; Veterans Affairs Eastern Colorado Health Care System, Aurora, CO, United States.
M ChangDepartment of Radiation Oncology, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, VA, United States.
C I AmosDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
E M SturgisDepartment of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
E GraboyesDepartment of Otolaryngology Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, United States; Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC, United States.
E Y ChiaoDepartment of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, United States; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
N Rogus-PuliaSpeech Pathology, University of Wisconsin School of Medicine, Madison, WI, United States; William S. Middleton Memorial Veterans Hospital, Madison, WI, United States.
J LewisDepartment of Pathology, Vanderbilt University Medical Center, Nashville, TN, United States.
A MadabhushiDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, United States; Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, United States.
M J FrederickBobby R. Alford Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States.
A SabichiDepartment of Medicine, Section of Hematology Oncology, Baylor College of Medicine, Houston, TX, United States; Medical Care Line, Department of Medicine, Section of Hematology/Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
M IttmannDepartment of Pathology, Baylor College of Medicine, Houston, TX, United States; Department of Pathology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
W G YarbroughDepartment of Otolaryngology/Head and Neck Surgery, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
C H ChungDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, United States.
R FerrarottoDepartment of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Weiyuan MaiDepartment of Radiation Oncology, Baylor College of Medicine, Houston, TX, United States; Department of Radiation Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
H D SkinnerDepartment of Radiation Oncology, UPMC, Pittsburgh, PA, United States.
U DuvvuriDepartment of Otolaryngology Head and Neck Surgery, UPMC, Pittsburgh, PA, United States; ENT Section, Operative Care Line, Pittsburgh Veterans Affairs Medical Center, Pittsburgh, PA, United States.
P GerngrossDental Service Line, Michael E. DeBakey VA Medical Center, Houston, TX, United States.
A G SikoraBobby R. Alford Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States; ENT Section, Operative Care Line, Michael E. DeBakey VA Medical Center, Houston, TX, United States. Electronic address: Andrew.Sikora@bcm.edu.
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · USThe University of Texas MD Anderson Cancer Center · USCase Western Reserve University · USHunter Holmes McGuire VA Medical Center · USMedical University of South Carolina · USMoffitt Cancer Center · USUniversity of Michigan–Ann Arbor · USUniversity of North Carolina at Chapel Hill · USUniversity of Wisconsin–Madison · USVA Eastern Colorado Health Care System · USVanderbilt University Medical Center · USVeterans Health Administration · USWilliam S. Middleton Memorial Veterans Hospital · US

Funding

Immunogenetic determinants of HPV-related head and neck cancer in VeteransI01BX004420 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI WHITE, DONNA LORRAINE · 2019 to 2020
–
Role of Adaptive Immunity in Lung Cancer Response to Oncogene-targeted TherapeuticsI01BX004751 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI LYNN E HEASLEY · 2019 to 2026
–
BLRD VA I01 BX004420BLRD VA I01 BX004751
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansOropharyngeal NeoplasmsPapillomaviridaePapillomavirus InfectionsRisk AssessmentUnited StatesVeteransHPVOropharynxRadiationTobaccoTumor immune microenvironmentVeteran

Identifiers

PMID31648864
PMCPMC7260859
OpenAlexW2981653634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.